| Literature DB >> 24365130 |
Tammy Quinlan1, Kimberlee A Musser1, Salvatore A Currenti2, Shelley M Zansky2, Tanya A Halse3.
Abstract
The first report of pertactin-negative variants of Bordetella pertussis in the United States has raised questions about the role of acellular pertussis vaccines in the recent increase of pertussis cases. Our laboratory utilized a sequence-based method to identify mutations in the pertactin gene responsible for these variants and assessed vaccination status from the associated cases. Published by Elsevier Ltd.Keywords: Acellular vaccine; Bordetella pertussis; Pertactin-negative variants
Mesh:
Substances:
Year: 2013 PMID: 24365130 DOI: 10.1016/j.mcp.2013.12.003
Source DB: PubMed Journal: Mol Cell Probes ISSN: 0890-8508 Impact factor: 2.365